Cohance Lifesciences Limited (BOM:543064)
India
· Delayed Price · Currency is INR 542.20
-6.90 (-1.26%)
At close: Dec 5, 2025
Cohance Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Market Capitalization | 207,562 | 293,004 | 172,366 | 120,256 | 157,436 | 126,468 | Upgrade
|
| Market Cap Growth | -36.35% | 69.99% | 43.33% | -23.61% | 24.49% | 394.20% | Upgrade
|
| Enterprise Value | 209,433 | 287,341 | 165,176 | 117,048 | 156,449 | 127,128 | Upgrade
|
| Last Close Price | 542.20 | 1159.80 | 676.60 | 472.70 | 608.03 | 483.61 | Upgrade
|
| PE Ratio | 117.27 | 109.38 | 57.40 | 29.24 | 34.69 | 34.90 | Upgrade
|
| PS Ratio | 17.15 | 24.47 | 16.40 | 8.97 | 11.93 | 12.53 | Upgrade
|
| PB Ratio | 5.29 | 15.92 | 8.40 | 6.93 | 10.31 | 10.71 | Upgrade
|
| P/TBV Ratio | 8.53 | 29.97 | 8.67 | 7.19 | 10.32 | 10.73 | Upgrade
|
| P/FCF Ratio | 151.96 | 221.22 | 51.78 | 70.21 | 61.79 | 46.55 | Upgrade
|
| P/OCF Ratio | 99.93 | 101.68 | 44.80 | 26.30 | 47.71 | 33.06 | Upgrade
|
| EV/Sales Ratio | 17.30 | 23.99 | 15.71 | 8.73 | 11.85 | 12.59 | Upgrade
|
| EV/EBITDA Ratio | 67.54 | 70.85 | 40.39 | 20.44 | 27.00 | 28.85 | Upgrade
|
| EV/EBIT Ratio | 99.50 | 87.58 | 46.61 | 22.25 | 28.89 | 31.02 | Upgrade
|
| EV/FCF Ratio | 153.33 | 216.94 | 49.62 | 68.34 | 61.40 | 46.79 | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.15 | 0.03 | 0.04 | 0.06 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 1.45 | 0.69 | 0.16 | 0.12 | 0.17 | 0.32 | Upgrade
|
| Debt / FCF Ratio | 3.30 | 2.11 | 0.20 | 0.41 | 0.38 | 0.53 | Upgrade
|
| Asset Turnover | 0.30 | 0.45 | 0.50 | 0.71 | 0.80 | 0.76 | Upgrade
|
| Inventory Turnover | 0.84 | 1.85 | 1.32 | 1.87 | 2.24 | 2.19 | Upgrade
|
| Quick Ratio | 1.59 | 1.78 | 8.61 | 4.17 | 3.85 | 1.56 | Upgrade
|
| Current Ratio | 2.92 | 2.43 | 10.68 | 6.37 | 5.36 | 2.57 | Upgrade
|
| Return on Equity (ROE) | 5.51% | 13.61% | 15.86% | 25.21% | 33.52% | 35.78% | Upgrade
|
| Return on Assets (ROA) | 3.26% | 7.76% | 10.50% | 17.33% | 20.49% | 19.35% | Upgrade
|
| Return on Capital (ROIC) | 4.08% | 9.68% | 11.30% | 19.18% | 22.96% | 21.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.30% | 12.30% | 16.60% | 29.10% | 33.40% | 32.70% | Upgrade
|
| Earnings Yield | 0.85% | 0.91% | 1.74% | 3.42% | 2.88% | 2.86% | Upgrade
|
| FCF Yield | 0.66% | 0.45% | 1.93% | 1.42% | 1.62% | 2.15% | Upgrade
|
| Dividend Yield | - | - | - | - | 0.33% | 0.41% | Upgrade
|
| Payout Ratio | - | - | - | 49.52% | 11.22% | 7.03% | Upgrade
|
| Buyback Yield / Dilution | -0.56% | -0.49% | - | - | - | 0.00% | Upgrade
|
| Total Shareholder Return | -0.56% | -0.49% | - | - | 0.33% | 0.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.